The p75 Neurotrophin Receptor, Relative to Other Schwann Cell and Melanoma Markers, Is Abundantly Expressed in Spindled Melanomas
- 1 August 2001
- journal article
- research article
- Published by Wolters Kluwer Health in The American Journal of Dermatopathology
- Vol. 23 (4) , 288-294
- https://doi.org/10.1097/00000372-200108000-00002
Abstract
Seventeen cases of spindled melanomas and eleven cases of epithelioid melanomas were immunolabeled with various melanoma and Schwann cell markers. Standard melanoma markers included S100, HMB45, HMB50, tyrosinase, and Melan A. Schwann cell markers included the p75 neurotrophin receptor (p75NTR), glial fibrillary acidic protein (GFAP), and the L1 adhesion protein. The degree of immunocytochemical labeling was scored by levels of both intensity and pervasiveness. The results confirmed a distinct difference in labeling between epithelioid and spindled melanomas. The p75NTR was strongly expressed in spindled melanomas and weakly expressed in the epithelioid melanomas. The usual melanoma markers, including HMB45, HMB50, MelanA, and tyrosinase had the reverse pattern, being strongly expressed in virtually all epithelioid melanomas, but rarely expressed in the spindled variants. S100 was unique among the markers in being expressed by both epithelioid and spindled melanomas. Glial fibrillary acidic protein and L1 adhesion protein were expressed moderately, with preferential labeling of the spindled melanomas. The greatest immunophenotypic difference between spindled and epithelioid melanomas was the high abundance of p75NTR expression in spindled melanomas. The functional significance of the high level of p75 neurotrophin receptor expression may contribute to the high predisposition of perineural extension in the desmoplastic subset of spindled melanomas.Keywords
This publication has 33 references indexed in Scilit:
- A103The American Journal of Surgical Pathology, 1998
- Comparison of immunohistochemical staining of the novel antibody melan‐A with S100 protein and HMB‐45 in malignant melanoma and melanoma variantsHistopathology, 1998
- Desmoplastic and Spindle-cell Malignant MelanomaThe American Journal of Surgical Pathology, 1996
- p75 nerve growth factor receptor staining helps identify desmoplastic and neurotropic melanomaJournal of Cutaneous Pathology, 1996
- A Nonneuronal Isoform of Cell Adhesion Molecule L1: Tissue‐Specific Expression and Functional AnalysisJournal of Neurochemistry, 1996
- Desmoplastic malignant melanomaJournal of the American Academy of Dermatology, 1995
- Comparison of five antimelanoma antibodies for identification of melanocytic cells on tissue sections in routine dermatopathologyJournal of the American Academy of Dermatology, 1989
- Recognition of malignant melanoma by monoclonal antibody HMB‐45. An immunohistochemical study of 200 paraffin‐embedded cutaneous tumorsJournal of Cutaneous Pathology, 1988
- Monoclonal antibodies specific for glial fibrillary acidic (GFA) protein and for each of the neurofilament triplet polypeptidesDifferentiation, 1984
- Monoclonal antibody UJ 127:11 detects a 220,000‐240,000 kdal. Glycoprotein present on a sub‐set of neuroectodermally derived cellsInternational Journal of Cancer, 1983